Skip to main content
Full access
Letter to the Editor
Published Online: 1 December 2001

Olanzapine-Induced Priapism

To the Editor: Priapism is a condition that has long been associated with use of psychotropic medications. Previous cases of priapism have been reported in association with several antipsychotic drugs, including chlorpromazine, thioridazine, thiothixene, mesoridazine, and perphenazine. The first discussion of priapism associated with administration of atypical antipsychotics, to our knowledge, is a case report from 1992 involving administration of clozapine (1). There have since been reports of priapism in patients receiving the atypical antipsychotics risperidone and olanzapine. We are aware of only four reports of olanzapine-induced priapism to date (25). Recent or concurrent use of other psychotropic agents makes definitive statements regarding the cause of priapism difficult for three of these patients (24). The other patient had reversible priapism after olanzapine monotherapy (5). We report here on the first instance, to our knowledge, of olanzapine-induced irreversible priapism in a neuroleptic-naive patient.
Mr. A was a 35-year-old white man who was admitted to a partial hospitalization program for patients with suicidal thoughts and paranoia. He had neither a prior history of mental illness nor a history of psychotropic medication use. Mr. A came in for treatment with paranoid delusions and suicidal thoughts and was diagnosed with schizoaffective disorder. Treatment with 10 mg of olanzapine at bedtime was initiated. Approximately 14 hours after his first and only dose of olanzapine, Mr. A developed a painful erection. He did not report this to anyone at the time and returned to the partial hospitalization program 48 hours later. By this time he was in significant discomfort and acknowledged that his pain was due to an erection that had been present for approximately 2 days. He was immediately taken to the emergency room for a urological consultation.
A urologist attempted evacuation of blood from Mr. A’s penis without success. Mr. A was then taken to the operating room, where blood was evacuated and phenylephrine was injected; flaccidity was obtained and lasted for 1 hour before the erection returned. Mr. A was taken back to the operating room, and a corporeal glandular shunt was placed, but this too was unsuccessful in alleviating the erection. He was then transferred to another hospital for possible insertion of a proximal shunt, which was not performed because of the length of time since the onset of priapism. Symptomatic relief was provided with oral analgesics; eventual detumescence of the penis followed. Permanent impotence resulted from Mr. A’s prolonged priapism.
Olanzapine can induce priapism because of its α-adrenergic blocking capabilities. While the condition is far from common, clinicians should be aware of olanzapine’s ability to induce priapism. Swift recognition is necessary to prevent permanent urological sequelae.

References

1.
Seftel AD, Saenz de Tejada I, Szetela B, Cole J, Goldstein I: Clozapine-associated priapism: a case report. J Urol 1992; 147:146-148
2.
Thompson JW Jr, Ware MR, Blashfield RK: Psychotropic medication and priapism: a comprehensive review. J Clin Psychiatry 1990; 51:430-433
3.
Heckers S, Anick D, Boverman JF, Stern TA: Priapism following olanzapine administration in a patient with multiple sclerosis. Psychosomatics 1998; 39:288-290
4.
Gordon M, de Groot CM: Olanzapine-associated priapism (letter). J Clin Psychopharmacol 1999; 19:192
5.
Deirmenjian JM, Erhart SM, Wirshing DA, Spellberg BJ, Wirshing WC: Olanzapine-induced reversible priapism: a case report. J Clin Psychopharmacol 1998; 18:351-353

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 2087-a - 2088

History

Published online: 1 December 2001
Published in print: December 2001

Authors

Affiliations

DOUGLAS A. SONGER, M.D.
JAMES C. BARCLAY, M.D.
Dayton, Ohio

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share